1-11 of 11
Johan Aschan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Honeur (Heamatology Outcomes Network in Europe): A Federated Model to Support Real World Data Research in Hematology

Kristina Bardenheuer, MSc Epi, Alun Passey, PhDTranslational Oncology, Maria d'Errico, PhDPhysics, Barbara Millier, MBA, Carine Guinard-Azadian, MD, Johan Aschan, MD PhD, Michel van Speybroeck, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 4839.
https://doi.org/10.1182/blood-2018-99-111093
Published: 2018
Journal Articles

Is Renal Impairment Still a Poor Prognostic Marker in Myeloma Care?: A Population Based Study Including 1542 Patients

Katarina Uttervall, MD, PhD-student, Johan Andreasson, Johan Liwing, Per Näsman, Johan Aschan, MD, PhD, Hareth Nahi
Journal: Blood
Blood (2012) 120 (21): 5033.
https://doi.org/10.1182/blood.V120.21.5033.5033
Published: 2012
Journal Articles

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.

Hareth Nahi, Johan Liwing, Anders Aldrin, Johan Andreasson, Cecilie Blimark, MD, Kristina Carlson, Jon Enestig, Max Flogegård, Karin Forsberg, Astrid Gruber, MD, PhD, Peter Johansson, MD, PhD, Helene Kviele, Birgitta Lauri, Ulf-Henrik Mellqvist, MD, PhD, Per Näsman, Agneta Swedin, Magnus Svensson, Katarina Uttervall, MD, PhD-student, Johan Aschan, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2970.
https://doi.org/10.1182/blood.V120.21.2970.2970
Published: 2012
Journal Articles

Follow-up of Real Life Treated Multiple Myeloma Patients: Response, Disease Progression and Overall Survival,

Hareth Nahi, Johan Liwing, Katarina Uttervall, Johan Andreasson, Astrid Gruber, MD, PhD, Per Näsman, Johan Aschan
Journal: Blood
Blood (2011) 118 (21): 3937.
https://doi.org/10.1182/blood.V118.21.3937.3937
Published: 2011
Journal Articles

Optimal Treatment Sequencing In Multiple Myeloma: An Exploratory Modeling Approach

Bart Heeg, Michel van Agthoven, Johan Liwing, Ulf-Henrik Mellqvist, Torben Plesner, Floris Logman, Verena Donatz, Johan Aschan, Hermann Einsele, Martin Kropff, Maarten Treur, Mirjam Barendse, Jean-Luc Harousseau, Antonio Palumbo, Pieter Sonneveld
Journal: Blood
Blood (2010) 116 (21): 3046.
https://doi.org/10.1182/blood.V116.21.3046.3046
Published: 2010
Journal Articles

Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients after Stem Cell Transplantation.

Gayane Avetisyan, MD, Johan Aschan, MD, PhD, Moustapha Hassan, Per Ljungman
Journal: Blood
Blood (2007) 110 (11): 2993.
https://doi.org/10.1182/blood.V110.11.2993.2993
Published: 2007
Journal Articles

Impact of Conditioning on the Outcome of Allografting in Myelofibrosis with Myeloid Metaplasia: Better Survival with Reduced Intensity Approach in Patients ≥50 Years.

Vikas Gupta, Nicolaus Kroger, Johan Aschan, Brian Leber, Christopher Dalley, Mitchell Sabloff, Jeffrey H. Lipton, Hans Messner, Wei Xu, Mats Brune
Journal: Blood
Blood (2007) 110 (11): 1095.
https://doi.org/10.1182/blood.V110.11.1095.1095
Published: 2007
Journal Articles

Fatal Infectious Complications Developing Late after Allogeneic Stem Cell Transplantation.

Andreas Bjorklund, MD, Johan Aschan, Olle Ringden, Jacek H. Winiarski, Per T. Ljungman
Journal: Blood
Blood (2005) 106 (11): 3239.
https://doi.org/10.1182/blood.V106.11.3239.3239
Published: 2005
Journal Articles

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

Clinical Trials & Observations Brief Report
Mehmet Uzunel, Jonas Mattsson, Mats Brune, Jan-Erik Johansson, Johan Aschan, Olle Ringdén
Journal: Blood
Blood (2003) 101 (2): 469–472.
https://doi.org/10.1182/blood-2002-02-0571
Published: 2003
Journal Articles

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

Clinical Trials & Observations
Britt-Marie Svahn, Mats Remberger, Karl-Erik Myrbäck, Katarina Holmberg, Britta Eriksson, Patrik Hentschke, Johan Aschan, Lisbeth Barkholt, Olle Ringdén
Journal: Blood
Blood (2002) 100 (13): 4317–4324.
https://doi.org/10.1182/blood-2002-03-0801
Published: 2002
Journal Articles

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Clinical Trials & Observations
Mats Remberger, Oolle Ringdén, Igor-Wolfgang Blau, Hellmut Ottinger, Bernhard Kremens, Micheil G. Kiehl, Johan Aschan, Dietrich W. Beelen, Nadezda Basara, Gunilla Kumlien, Axel A. Fauser, Volker Runde
Journal: Blood
Blood (2001) 98 (6): 1739–1745.
https://doi.org/10.1182/blood.V98.6.1739
Published: 2001